CN Patent

CN108570036A — 一种btk抑制剂的多晶型物及其制备方法

Assigned to Capital Pharmaceutical Holdings (Beijing) Co., Ltd. · Expires 2018-09-25 · 8y expired

What this patent protects

本发明涉及一种BTK抑制剂的多晶型物及其制备方法 。

USPTO Abstract

本发明涉及一种BTK抑制剂的多晶型物及其制备方法 。

Drugs covered by this patent

Patent Metadata

Patent number
CN108570036A
Jurisdiction
CN
Classification
—
Expires
2018-09-25
Drug substance claim
No
Drug product claim
No
Assignee
Capital Pharmaceutical Holdings (Beijing) Co., Ltd.
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.